GlycoMimetics, Inc. (GLYC) Social Stream
Featured Post From StockTwits About GLYC
$GLYClqqkerinsiderDOTcom, published April 26, 2021
ATTENTION: Mr Market Maker
RE: My future GlycoMimetics windfall
I have now sold 1,783 Jan'22 $2.5 puts on GLYC. Just wanted to provide a heads up notice, that if you don't plan in having the price below $2.50 at market close on 01.21.22, you will be forced to write me a check for $129,517.99. Just wanted to provid a heads up notice so you can start getting my payment ready.
Other Notable StockTweets About GLYC
$GLYC having held a large stake in GLYC shares, and trading around this core, for over a year now, it has become most apparent that indeed the large institutional position exacerbates the effects of a sector downturn on GLYC as well as tempering any past breakouts (has been a year since even reaching 5/share).
Yet GLYC is clearly a solid company financially speaking and one with excellent science assets. So, after all this observation, what do I think?
I think until we get news that is profound enough to quash any short attacks such that we breeze on through 4s and 5s and head higher for good, we are likely to stay range-bound. But this insight is helpful... How?
Well, while the mid 2s are unpleasant, voices speaking of the 1s are noise, you can be sure every bit as much as voices of the 6s and 7s are noise when we find ourselves back in low 4s again (I hope soon).
And BTW, I expect we get that profound news by early 2022 to finally take us on up, up, up. JMO
$GLYC I'm feeling much better about my investment. I feel for those who sold too soon. You could have had a V8. Keep sharing your feelings about the price movement. We live for your feelings. Have a good weekend and be careful what you feel...one can get arrested for feeling the wrong thingie.Provocateur1, published April 16, 2021
$GLYC just buy the dips imo if you don't need the cash right away or till at least 2022. This should move up - trading very close to cash on good news. I have put my limit sell order at the max share price fidelity allowed me. I will be adding more over the month and into 2022.
Almost all Bio stocks are down so GLYC is following the sector. AML ph3 data next year. If anything, tutes will pump it up leading into AML data to dump onto retail of bad news.
Also, take into consideration this piece released today